期刊文献+

2型糖尿病临床路径管理体系的可行性研究

The Feasibility Study of Type 2 Diabetes Clinical Pathway Management System
下载PDF
导出
摘要 目的探讨2型糖尿病临床路径管理体系的可行性。方法选取2013年8月—2014年7月在该院收治的40例2型糖尿病患者为研究对象,随机分为观察组与对照组,每组各20例。给予对照组常规住院治护管理;给予观察组临床路径式治护管理。对比两组患者的住院时间、费用、血糖控制情况。结果观察组住院时间及平均住院费用明显小于对照组;而且两组治疗后的血糖水平明显低于同组治疗前的水平;同时,治疗后观察组血糖水平明显低于对照组,以上比较差异具有统计学意义(P<0.05)。结论相比于常规护理管理,根据临床路径管理体系对2型糖尿病患者进行护理治疗的效果更加明显,能够缩短患者住院时间、减少住院费用,有效控制血糖水平,提高患者对治疗的满意度,进而提高患者生活质量。因此,该方法值得临床推广应用。 Objective To study the feasibility of type 2 diabetes clinical pathway management system.Methods To choose between August 2013 and July 2013 in our hospital of 40 cases of patients with type 2 diabetes as the research object,were randomly divided into observation group and control group,20 cases in each group.Give control group routine in hospital nursing management;To observe clinical path type for nursing management.Comparison of two groups of patients in hospital time,cost,and glycemie control.Results The length of hospital stay and average hospitalization expenses observation group was obviously less than control group;And the two groups after treatment of blood glucose levels significandy lower than before treatment in the same group level.At the same time,the observation group blood sugar levels significantly lower than the control group after treatment;The above comparison differences statistically significant(P〈0.05).Conclusion Compared with the conventional nursing management,according to the clinical pathway management system in patients with type 2 diabetes for care and treatment effect is more apparent,can shorten the length of hospital stay,reduce hospitalization expenses,and patients to effectively control blood sugar levels,improve patient satisfaction,to thus improve patient quality of life.Therefore,this method is worthy of clinical application.
作者 段玉贞
出处 《糖尿病新世界》 2015年第12期140-141,共2页 Diabetes New World Magazine
关键词 2型糖尿病 临床路径管理体系 可行性 Type 2 diabetes A clinical pathway management system The feasibility of
  • 相关文献

参考文献5

二级参考文献65

  • 1王长远,秦俭.临床路径在医学领域的应用[J].中国误诊学杂志,2007,7(6):1169-1170. 被引量:12
  • 2Pickup JC,et al.Inflammation and Activated Innate Immunity in the Pathoganesis of Type 2 Diabetes[J].J Diabetes Care,2004,27:813-823.
  • 3Weyer C,Tataranni PA,Bogardus C,et al.Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolemnce during each stage of type 2 diabetes development[J].J Diabetes Care,2000,24:89-94.
  • 4United Kingdom Prospective Diabetes Study Group.UK Prospective Diabetes Study 16:overview of 6 years' therapy of type Ⅱ diabetes:a progressive disease[J].Diabetes,1995,44:1249-1258.
  • 5Schiffrin EL.Endethelin:role in experimental hypertension[J].J Cardiovasc Pharmacol,2000,35:s33-35.
  • 6Olfasky JM.Treatment of insulin resistance with peroxisome proliferatoractivated receptor agonists[J].J Clin Invest,2000,106:467-472.
  • 7Kabadi MU,Kabadi UM.Effects of glimepiride on insulin secretion and sensitvity in patients with recently diagnosed type2 diabetes mellitus[J].J Clin Ther,2004,26(1):63-69.
  • 8Korytkowski M,Thomsa,Reidl,et al.Glimepiride improves both first and second phase of insulin secretion type2diabetes[J].J Diabetes Care,2002,25(9):1607-1611.
  • 9中华医学会糖尿病学分会,中华医学会外科学分会.手术治疗糖尿病专家共识[J].中华糖尿病杂志,2011,3(3):205-208.
  • 10American Diabetes Association. Standards of medical care in Diabetes--2009[J]. Diabetes Care, 2009,32 (suppl 1): S13-61.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部